Reply to ‘Re: Essential Thrombocythemia in Young Individuals: Frequency and Risk Factors for Vascular Events and Evolution to Myelofibrosis in 126 Patients. Alvarez-Larrán Et Al. Leukemia 2007; 21: 1218–1223’

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404966
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Reply to ‘Re: Essential Thrombocythemia in Young Individuals: Frequency and Risk Factors for Vascular Events and Evolution to Myelofibrosis in 126 Patients. Alvarez-Larrán a Et Al.’ by Westerman Et Al.

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

JAK2 Mutation Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2011English

Incidence and Risk Factors for Bleeding in 1104 Patients With Essential Thrombocythemia or Prefibrotic Myelofibrosis Diagnosed According to the 2008 WHO Criteria

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Recent Advances in Understanding Myelofibrosis and Essential Thrombocythemia

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Myelofibrotic Transformation in Essential Thrombocythemia. Author Reply

Haematologica
Hematology
2009English

In Reply to Park Et Al

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

In Reply to Tin Et Al.

International Journal of Colorectal Disease
Gastroenterology
2015English

Red Herrings Remain in Geographical Ecology: A Reply to Hawkins Et Al. (2007)

Ecography
EvolutionEcologySystematicsBehavior
2007English

Comment on Lipsky Et Al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

Haematologica
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy